Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Employment agrmnt
Quarterly results
Appointed director
|
|
Receptos, Inc. (RCPT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/14/2014 |
8-K
| Appointed a new director|
Docs:
|
"Receptos Announces Appointment of Mary Lynne Hedley, Ph.D. as Director San Diego, CA, April 14, 2014 — Receptos, Inc. , a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, today announced the appointment of Mary Lynne Hedley, Ph.D. as a director of Receptos. Dr. Hedley will serve as a Class I director with a term of office expiring and to be renewed at the 2014 annual meeting of stockholders. Dr. Hedley will also serve as a member of the Board's Nominating and Corporate Governance Committee. Dr. Hedley has served as president of Tesaro, Inc. and as a member of its Board of Directors since co-founding Tesaro in March 2010. From July 2009 to February 2010, Dr. Hedley served as executive vice president of operations and chief scien..." |
|
| 07/22/2013 |
8-K
| Appointed a new director |
|
|